Sea Mild Biotechnology Co., Ltd. manufactures and sells multi-purpose natural lotions based on sea salt in Taiwan.
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$7.90|
|52 Week High||NT$7.13|
|52 Week Low||NT$15.73|
|1 Month Change||1.67%|
|3 Month Change||-13.09%|
|1 Year Change||-49.14%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-80.71%|
Recent News & Updates
|7516||TW Household Products||TW Market|
Return vs Industry: 7516 underperformed the TW Household Products industry which returned -26% over the past year.
Return vs Market: 7516 underperformed the TW Market which returned 33.6% over the past year.
Stable Share Price: 7516 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 7516's weekly volatility (5%) has been stable over the past year.
About the Company
Sea Mild Biotechnology Co., Ltd. manufactures and sells multi-purpose natural lotions based on sea salt in Taiwan. It offers cleaning products for clothing, home, and personal cleaning, as well as other commercial specifications under the Sea Mild brand name. The company also exports its products.
Sea Mild Biotechnology Fundamentals Summary
|7516 fundamental statistics|
Is 7516 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|7516 income statement (TTM)|
|Cost of Revenue||NT$143.68m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-3.77|
|Net Profit Margin||-48.01%|
How did 7516 perform over the long term?See historical performance and comparison
Is Sea Mild Biotechnology undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 7516's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 7516's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 7516 is unprofitable, so we can't compare its PE Ratio to the TW Household Products industry average.
PE vs Market: 7516 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 7516's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 7516 is good value based on its PB Ratio (1.4x) compared to the TW Household Products industry average (2.1x).
How is Sea Mild Biotechnology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sea Mild Biotechnology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Sea Mild Biotechnology performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7516 is currently unprofitable.
Growing Profit Margin: 7516 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 7516 is unprofitable, and losses have increased over the past 5 years at a rate of 49.3% per year.
Accelerating Growth: Unable to compare 7516's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 7516 is unprofitable, making it difficult to compare its past year earnings growth to the Household Products industry (26%).
Return on Equity
High ROE: 7516 has a negative Return on Equity (-68.52%), as it is currently unprofitable.
How is Sea Mild Biotechnology's financial position?
Financial Position Analysis
Short Term Liabilities: 7516's short term assets (NT$115.7M) exceed its short term liabilities (NT$58.9M).
Long Term Liabilities: 7516's short term assets (NT$115.7M) exceed its long term liabilities (NT$20.7M).
Debt to Equity History and Analysis
Debt Level: 7516 is debt free.
Reducing Debt: 7516 has no debt compared to 5 years ago when its debt to equity ratio was 73.6%.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7516 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 7516 has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 4% each year.
What is Sea Mild Biotechnology current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 7516's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 7516's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 7516's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 7516's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 7516's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
Sea Mild Biotechnology has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sea Mild Biotechnology Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Sea Mild Biotechnology Co., Ltd.
- Ticker: 7516
- Exchange: TPEX
- Founded: NaN
- Industry: Household Products
- Sector: Household
- Market Cap: NT$152.541m
- Shares outstanding: 19.31m
- Website: https://www.seamild.com.tw
Number of Employees
- Sea Mild Biotechnology Co., Ltd.
- No. 43, Guanye East Road
- Pingzhen District
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/19 08:35|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.